2001 Surveillance Slides

This is an archived document. The links and content are no longer being updated.

Return to 2001 Surveillance Slides Main Menu

Completion of TB Therapy

United States, 1993-1999

Slide 25: Completion of TB Therapy, United States, 1993-1999. The reporting areas began collecting information on completion of therapy in 1993 through the individual TB case report form. This slide is based on data received at CDC by April 2002. Patients with an initial isolate resistant to rifampin and children with meningeal, bone or joint, or miliary disease were excluded from the calculations. Overall completion remained at approximately 90%; however, completion of therapy in 1 year or less increased from <65% in 1993 to 80% in 1998 and 1999. The current national program goal is completion of therapy in 1 year or less in 90% of patients. CDC is working with state and local health departments to evaluate reasons for apparently delayed completion of therapy, which may vary by jurisdiction.

Back to 2001 Surveillance Slides Main Page

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: tbinfo@cdc.gov

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov